ESC Premium Access

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Congress Presentation

About the speaker

Doctor Michael Zile

Medical University of South Carolina, Charleston (United States of America)
5 presentations
0 follower

9 more presentations in this session

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Speaker: Doctor Y. Mareev (Haifa, IL)

Thumbnail

Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT.

Speaker: Professor J. Cleland (Glasgow, GB)

Thumbnail

The glucagon-like peptide 1 agonist liraglutide increases heart rate in heart failure patients

Speaker: Doctor R. Tougaard (Aarhus, DK)

Thumbnail

Long-term outcome in myocardial infarction patients with heart failure treated with aldosterone receptor antagonist in relation to ejection fraction and kidney function

Speaker: Doctor I. Lofman (Stockholm, SE)

Thumbnail

Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials

Speaker: Doctor I. Pina (Philadelphia, US)

Thumbnail

Access the full session

Can we teach heart failure drugs new tricks?

Speakers: Doctor M. Zile, Doctor Y. Mareev, Professor J. Cleland, Doctor R. Tougaard, Doctor I. Lofman...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb